Suzuken

Nagoya, Japan Founded: 1932 • Age: 94 yrs
Pharmaceutical distribution and healthcare services are provided by Suzuken.
Annual revenue $16.1B Latest available
Total funding - Funding intelligence
Employees 12920 Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Suzuken

Suzuken is a company based in Nagoya (Japan) founded in 1932. The company has 12,920 employees as of March 31, 2024. Suzuken operates in a competitive market with competitors including AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.

  • Headquarter Nagoya, Japan
  • Employees 12920 as on 31 Mar, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Suzuken Co., Ltd.
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $16.06 B (USD)
    0.56
    as on Mar 31, 2025
  • Net Profit
    $230.87 M (USD)
    18.89
    as on Mar 31, 2025
  • EBITDA
    $329.18 M (USD)
    12.77
    as on Mar 31, 2025
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    12920

    as on Mar 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Suzuken

Suzuken is a publicly listed company on the TSE with ticker symbol 9987 in Japan, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: TSE · Ticker: 9987 · Sector: Distribution services · Japan

Funding Insights of Suzuken

Premium access

Detailed funding history for Suzuken

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Suzuken

Investments
Premium access

Investment portfolio details for Suzuken

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Suzuken

Premium access

Detailed financials for Suzuken

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Suzuken Comparisons

Suzuken Primary company
Description
Pharmaceutical distribution and healthcare services are prov...
Location
Nagoya, Japan
Founded Year
1932
Annual Revenue
$16.06 B (USD)
Net Profit
$230.87 M (USD)
EBITDA
$329.18 M (USD)
Employees
12,920
As of 2024
Premium access

Peer comparison for Suzuken

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Suzuken

Suzuken operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Pfizer, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Pharmaceutical distribution and supply chain services are provided globally.
Locked Locked Locked
Pharmaceutical products for treating multiple diseases are provided.
Locked Locked Locked
Branded pharmaceutical products are developed, marketed, and distributed globally.
Locked Locked Locked
India's leading healthcare products distribution platform
Locked Locked Locked
Wholesaler & distributor of healthcare, medical, and pharmaceutical products
Locked Locked Locked
Diversified drugs are distributed by Renee in the United States.
Premium access

Detailed competitors of Suzuken

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Suzuken

Premium access

Complete news archive for Suzuken

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suzuken

Suzuken was founded in 1932.

Suzuken is headquartered in Nagoya, Japan. It is registered at Nagoya, Aichi, Japan.

Yoshiki Welfare is the current CEO of Suzuken.

As of Mar 31, 2024, the latest employee count at Suzuken is 12,920.

Annual revenue of Suzuken is $16.06B as on Mar 31, 2025.

Suzuken was founded in 1932 in Nagoya, Japan, and operates within the pharmaceutical sector. Distribution of pharmaceuticals is handled by the company, alongside logistics support, nursing care, and healthcare services offered to businesses. Operations are centered in Japan, with annual revenues of 17.54B recorded in 2022 and a net profit of 0.15B achieved during that period.

Suzuken's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.

Yes, Suzuken is publicly traded on TSE under the ticker symbol 9987.

The ticker symbol of Suzuken is 9987 on TSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available